Idiopathic pulmonary fibrosis

Cancer Incidence in Five Continents

Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,378

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196

Fleischner Society: Glossary of Terms for Thoracic Imaging

Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Rémy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,189

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975

Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement

(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,651

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline

Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916

Double-edged mitophagy: balancing inflammation and resolution in lung disease

Tian, S., Zhang, Y., Liu, C. X., Zhang, H., Lu, Q., Zhao, Y., & Fan, H. (2025) · Clinical Science · doi:10.1042/cs20256705 · Cited by 29

Identification of Halophilic Microbes in Lung Fibrotic Tissue by Oligotyping

D’Alessandro‐Gabazza, C. N., Méndez–García, C., Hataji, O., Westergaard, S., Watanabe, F., Yasuma, T., Toda, M., Fujimoto, H., Nishihama, K., Fujiwara, K., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01892 · Cited by 28

Protective Role of the Nucleic Acid Sensor STING in Pulmonary Fibrosis

Savigny, F., Schricke, C., Lacerda‐Queiroz, N., Meda, M., Nascimento, M., Huot-Marchand, S., Monteiro, F. D. G., Ryffel, B., Gombault, A., Bert, M. L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.588799 · Cited by 27

Enhanced and long-term CT imaging tracking of transplanted stem cells labeled with temperature-responsive gold nanoparticles

Yu, C., Bao, H., Chen, Z., Li, X., Liu, X., Wang, W., Huang, J., & Zhang, Z. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02997a · Cited by 27

NEDD4L-induced β-catenin ubiquitination suppresses the formation and progression of interstitial pulmonary fibrosis via inhibiting the CTHRC1/HIF-1α axis

Chen, L., Yang, Y., Yan, H., Peng, X., & Zou, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57247 · Cited by 27

Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

Chang, K., Zhang, X., Lin, S., Lin, S., Lin, Y., Akhrymuk, I. V., Lin, S., & Lin, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011152 · Cited by 27

Risk factors for acute exacerbation of interstitial lung disease following lung cancer resection: a systematic review and meta-analysis

Hao, X., Hao, J., Chen, C., Peng, H., Zhang, J., Cao, Q., & Liu, L. (2021) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivab350 · Cited by 30

A missing piece of the puzzle in pulmonary fibrosis: anoikis resistance promotes fibroblast activation

Yin, J., Wang, J., Zhang, X., Liao, Y., Luo, W. F., Wang, S., Ding, J., Huang, J., Chen, M., Wang, W., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00761-2 · Cited by 26

Serum Uric Acid as a Diagnostic Biomarker for Rheumatoid Arthritis–Associated Interstitial Lung Disease

Wang, Z., Wang, W., Xiang, T., Gong, B., & Xie, J. (2022) · Inflammation · doi:10.1007/s10753-022-01661-w · Cited by 31

The molecular mechanisms of extracellular matrix-derived hydrogel therapy in idiopathic pulmonary fibrosis models

Evangelista-Leite, D., Carreira, A. C. O., Nishiyama, M. Y., Gilpin, S. E., & Miglino, M. A. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122338 · Cited by 27

An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis

Aryal, S., & Nathan, S. D. (2018) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2018.1471465 · Cited by 26

Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectives

Lin, Y., Shi, Y., Su, X., Ouyang, L., Wang, G., & Ye, T. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113714 · Cited by 26

Integrative omics analysis identifies biomarkers of idiopathic pulmonary fibrosis

Zheng, P., Sun, S., Wang, J., Cheng, Z. J., Lei, K. C., Xue, M., Zhang, T., Huang, H., Zhang, X. D., & Sun, B. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04094-0 · Cited by 27

MicroRNA-34a: A Novel Therapeutic Target in Fibrosis

Zhao, M., Qi, Q., Liu, S., Huang, R. S., Shen, J., Zhu, Y., Chai, J., Zheng, H., Wu, H., & Liu, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.895242 · Cited by 27

Lifestyle, Genetic Susceptibility, and the Risk of Idiopathic Pulmonary Fibrosis

Ma, Y., Cui, F., Li, D., Wang, J., Tang, L., Xie, J., Hu, Y., & Tian, Y. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.04.008 · Cited by 26

Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway

Alaaeldin, R., Mohyeldin, R. H., Bekhit, A. A., Gomaa, W. M., Zhao, Q., & Fathy, M. (2023) · Molecules · doi:10.3390/molecules28124665 · Cited by 26

Tuberostemonine may enhance the function of the SLC7A11/glutamate antiporter to restrain the ferroptosis to alleviate pulmonary fibrosis

Liu, Y., Tang, A., Liu, M., Xu, C., Cao, F., & Yang, C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116983 · Cited by 25

Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement

Neumann, E., Lepper, N., Vasile, M., Riccieri, V., Peters, M. A., Meier, F. M. P., Hülser, M.-L., Distler, O., Gay, S., Mahavadi, P., et al. (2019) · Cytokine · doi:10.1016/j.cyto.2018.11.013 · Cited by 26

Ability to Suppress TGF-β-Activated Myofibroblast Differentiation Distinguishes the Anti-pulmonary Fibrosis Efficacy of Two Danshen-Containing Chinese Herbal Medicine Prescriptions

Shao, R., Wang, F., Lyu, M., Yang, J., Zhang, P., & Zhu, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00412 · Cited by 27

Fibrosis in tissue engineering and regenerative medicine: treat or trigger?

Fernández‐Colino, A., Iop, L., Ferreira, M. S. V., & Mela, P. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.07.007 · Cited by 28

Psoralen attenuates bleomycin‐induced pulmonary fibrosis in mice through inhibiting myofibroblast activation and collagen deposition

Du, M., Duan, J., Zhang, C., Yang, H., Guan, X., Zhong, W., Liu, Y., Li, Z., Cheng, Y., Zhou, Y., et al. (2019) · Cell Biology International · doi:10.1002/cbin.11205 · Cited by 27

Therapeutic Targeting of IL-11 for Chronic Lung Disease

Kortekaas, R. K., Burgess, J. K., van Orsoy, R., Lamb, D. J., Webster, M. J., & Gosens, R. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.007 · Cited by 26

Relationship between asporin and extracellular matrix behavior: A literature review

Fan, R., Yan, X., & Zhang, W. (2022) · Medicine · doi:10.1097/md.0000000000032490 · Cited by 25

Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis

Dsouza, N. N., Alampady, V., Baby, K., Maity, S., Byregowda, B. H., & Nayak, Y. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01193-1 · Cited by 25

TGFβ1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation

Wu, M., Wang, Z., Shi, X., Zan, D., Chen, H., Yang, S., Ding, F., Liu, Y., Tan, P., Ma, R. Z., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02533-z · Cited by 25

Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis

Wu, Z., Shi, R., Yan, S., Zhang, S., Lü, B., Huang, Z., & Ji, L. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155368 · Cited by 25

Single-Cell RNA Sequencing Reveals Monocyte-Derived Interstitial Macrophages with a Pro-Fibrotic Phenotype in Bleomycin-Induced Pulmonary Fibrosis

Wang, S. F., Li, J., Wu, C., Lei, Z., Wang, T., Huang, X., Zhang, S., Liu, Y., Bi, X., Zheng, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111669 · Cited by 25

Inhibition of the ERK1/2-ubiquitous calpains pathway attenuates experimental pulmonary fibrosis in vivo and in vitro

Zou, M., Zhang, G., Zou, J., Liu, Y., Liu, B., Hu, X., & Cheng, Z. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111886 · Cited by 26

Astragalus polysaccharides attenuate pulmonary�fibrosis by inhibiting the epithelial-mesenchymal�transition and NF-κB pathway activation

Zhang, R., Xu, L., An, X., Sui, X., & Lin, S. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4574 · Cited by 27

Burden of idiopathic pulmonary fibrosis on patients’ emotional well being and quality of life: a literature review

Antoniou, K. M., Kamekis, A., Symvoulakis, E. K., Kokosi, M. A., & Swigris, J. J. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000703 · Cited by 26

Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix

Liu, Y., & Qi, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106774 · Cited by 25

Protective effect of melatonin entrapped PLGA nanoparticles on radiation-induced lung injury through the miR-21/TGF-β1/Smad3 pathway

Wang, S., Li, J., He, Y., Ran, Y., Lu, B., Gao, J., Shu, C., Li, J., Zhao, Y., Zhang, X., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120584 · Cited by 25

Lycopene attenuates bisphenol A–induced lung injury in adult albino rats: a histological and biochemical study

Faheem, N. M., Askary, A. E., & Gharib, A. F. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14140-w · Cited by 25

Iguratimod decreases bleomycin-induced pulmonary fibrosis in association with inhibition of TNF-α in mice

Shao, S., Qu, Z., Liang, Y., Xu, Y., Zhou, D., Li, D., Zhang, Y., & Yin, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107936 · Cited by 25

Serum levels of small HDL particles are negatively correlated with death or lung transplantation in an observational study of idiopathic pulmonary fibrosis

Barochia, A. V., Kaler, M. M., Weir, N. A., Gordon, E. M., Figueroa, D. M., Yao, X., Woldehanna, M. L., Sampson, M. L., Remaley, A. T., Grant, G. M., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04053-2020 · Cited by 25

A Senescence Bystander Effect in Human Lung Fibroblasts

Waters, D. W., Schuliga, M. J., Pathinayake, P. S., Wei, L., Tan, H.-Y., Blokland, K. E. C., Jaffar, J., Westall, G. P., Burgess, J. K., Prêle, C. M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091162 · Cited by 25

Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern

Achaiah, A., Rathnapala, A., Pereira, A. Z., Bothwell, H., Dwivedi, K., Barker, R., Benamore, R. E., Hoyles, R. K., Iotchkova, V., & Ho, L. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-000899 · Cited by 25

PEDF is an antifibrosis factor that inhibits the activation of fibroblasts in a bleomycin-induced pulmonary fibrosis rat model

Qin, X., Jia, C., Liang, J., Chen, J., Liu, X., Chao, Z., Qin, H., Yuan, Y., Liu, Z., Zhang, Z., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02027-4 · Cited by 25

Polymer-Based Delivery of Peptide Drugs to Treat Diabetes: Normalizing Hyperglycemia and Preventing Diabetic Complications

Jeon, H., Lee, A.-J., & Ha, K. (2022) · BioChip Journal · doi:10.1007/s13206-022-00057-0 · Cited by 26

Discovery of Aryloxyphenyl–Heptapeptide Hybrids as Potent and Selective Matrix Metalloproteinase-2 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis

Takeuchi, T., Hayashi, M., Tamita, T., Nomura, Y., Kojima, N., Mitani, A., Takeda, T., Hitaka, K., Kato, Y., Kamitani, M., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00613 · Cited by 26

Exosomes in pathogenesis, diagnosis, and treatment of pulmonary fibrosis

Yang, Y., Liu, Y., Chai, Y., Liu, K., Hu, W., Zhao, K., Zhu, Y., Gao, P., Huang, Q., & Zhang, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927653 · Cited by 25

Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk

Mohammadi‐Nejad, A., Allen, R. J., Kraven, L. M., Leavy, O. C., Jenkins, G. R., Wain, L. V., Auer, D. P., & Sotiropoulos, S. N. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104356 · Cited by 26

A comprehensive review of emodin in fibrosis treatment

HaoShang, Jia, X., Liu, H., Zhang, X., & Shao, Y. (2022) · Fitoterapia · doi:10.1016/j.fitote.2022.105358 · Cited by 25

Urine-derived exosomes from individuals with IPF carry pro-fibrotic cargo

Elliot, S. J., Catanuto, P., Pereira‐Simon, S., Xia, X., Shahzeidi, S., Roberts, E. R., Ludlow, J. W., Hamdan, S., Daunert, S., Parra, J., et al. (2022) · eLife · doi:10.7554/elife.79543 · Cited by 26

Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms

Ding, L., Qi, H., Wang, Y., Zhang, Z., Liu, Q., Guo, C., Liu, J., Chen, Z., Li, J., Chen, J., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114096 · Cited by 25

Local administration of liposomal-based Plekhf1 gene therapy attenuates pulmonary fibrosis by modulating macrophage polarization

Yan, L., Hou, C., Liu, J., Wang, Y., Zeng, C., Yu, J., Zhou, T., Zhou, Q., Duan, S., & Xiong, W. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2314-8 · Cited by 26

Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition

Pi, P., Zeng, Z., Zeng, L., Han, B., Bai, X., & Xu, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1218059 · Cited by 29

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience

Kawamura, K., Ichikado, K., Ichiyasu, H., Anan, K., Yasuda, Y. U., Suga, M., & Sakagami, T. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0880-0 · Cited by 24

Pregnancy exposure to carbon black nanoparticles exacerbates bleomycin-induced lung fibrosis in offspring via disrupting LKB1-AMPK-ULK1 axis-mediated autophagy

Zhang, L., Cheng, S., Jiang, X., Zhang, J., Meng, P., Tang, Q., Qin, X., Wang, B., Chen, C., & Zou, Z. (2019) · Toxicology · doi:10.1016/j.tox.2019.152244 · Cited by 25

Pharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options

Trachalaki, A., Irfan, M., & Wells, A. U. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1822326 · Cited by 25

Bletilla striata polysaccharide attenuated the progression of pulmonary fibrosis by inhibiting TGF-β1/Smad signaling pathway

Wang, S., Yu, J., Liu, Y., Yu, J., Ma, Y., Zhou, L., Liu, X., Liu, L., Li, W., & Niu, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117680 · Cited by 24

[68Ga]FAPI PET for Imaging and Treatment Monitoring in a Preclinical Model of Pulmonary Fibrosis: Comparison to [18F]FDG PET and CT

Ji, H., Song, X., Lv, X., Shao, F., Yu, L., Song, Y., Song, W., Qiao, P., Gai, Y., Jiang, D., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17060726 · Cited by 24

IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN/AKT/ERK pathway

Li, Y., Yin, H., Yuan, H., Wang, E., Wang, C., Li, H., Geng, X., Zhang, Y., & Bai, J. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03260-x · Cited by 23

S1PR1-biased activation drives the resolution of endothelial dysfunction-associated inflammatory diseases by maintaining endothelial integrity

Zheng, H., Yu, J., Gao, L., Wang, K., Xu, Z., Zeng, Z., Zheng, K., Tang, X., Tian, X., Zhao, Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57124-x · Cited by 26

Megakaryocytes participate in the occurrence of bleomycin-induced pulmonary fibrosis

Zhou, Y., Zhang, B., Li, C., Huang, X., Cheng, H., Bao, X., Zhao, F., Cheng, Q., Yue, S., Han, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1903-8 · Cited by 24

Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)

Khedoe, P. P. S. J., Marges, E. R., Hiemstra, P. S., Ninaber, M. K., & Geelhoed, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01990 · Cited by 24

Emerging physiological and pathological roles of MeCP2 in non-neurological systems

Wang, J., Xiao, Y., Liu, C., Huang, Y., Petersen, R. B., Zheng, L., & Huang, K. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108768 · Cited by 23

Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens

Testa, L. C., Julé, Y., Lundh, L., Bertotti, K., Merideth, M. A., O’Brien, K., Nathan, S. D., Venuto, D. C., El‐Chemaly, S., Malicdan, M. C. V., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.607720 · Cited by 24

TSSK4 upregulation in alveolar epithelial type-II cells facilitates pulmonary fibrosis through HSP90-AKT signaling restriction and AT-II apoptosis

Chen, H., He, A., Li, H., Chen, H., Xie, H., Luo, L., Huang, Y., Chen, J., Guan, J., He, Q., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04232-3 · Cited by 25

Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways

Lü, Y., Zhang, Y., Pan, Z., Yang, C., Chen, L., Wang, Y., Xu, D., Xia, H., Wang, S., Chen, S., et al. (2022) · Nutrients · doi:10.3390/nu14051094 · Cited by 27

Extracellular vesicles in respiratory disease

Carnino, J. M., & Lee, H. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.07.008 · Cited by 26

Thymol protects against bleomycin-induced pulmonary fibrosis via abrogation of oxidative stress, inflammation, and modulation of miR-29a/TGF-β and PI3K/Akt signaling in mice

Hussein, R. M., Arafa, E. A., Raheem, S. A., & Mohamed, W. R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121256 · Cited by 24

Smoking-related interstitial lung disease

Gotarredona, M. P. S., Herrero, S. N., Izquierdo, L. G., & Portal, J. A. R. (2022) · Radiología (English Edition) · doi:10.1016/j.rxeng.2022.10.008 · Cited by 24

Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis

Ji, H.-M., Dong, H., Lan, Y., Bi, Y., Gu, X., Han, Y., Yang, C., Cheng, M.-H., & Gao, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1089812 · Cited by 24

Timosaponin BII inhibits TGF ‐β mediated epithelial‐mesenchymal transition through Smad‐dependent pathway during pulmonary fibrosis

Ding, D.-L., Shen, X., Yu, L., Zheng, Y., Liu, Y., Wang, W., Liu, L., Zhao, Z., Nian, S., & Liu, L. (2023) · Phytotherapy Research · doi:10.1002/ptr.7774 · Cited by 24

Protective Effect of Tunisian Flaxseed Oil against Bleomycin-Induced Pulmonary Fibrosis in Rats

Abidi, A., Kourda, N., Feki, M., & Khamsa, S. B. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1622741 · Cited by 24

Treatment of idiopathic pulmonary fibrosis with Nintedanib: an update

Wongkarnjana, A., Yanagihara, T., & Kolb, M. R. J. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1673733 · Cited by 23

CD151 in Respiratory Diseases

Wong, A. H., & Tran, T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00064 · Cited by 24

Preparation, optimization, and in vivo evaluation of an inhaled solution of total saponins of Panax notoginseng and its protective effect against idiopathic pulmonary fibrosis

Liu, M., Zhang, T., Zang, C., Cui, X.-L., Li, J., & Wang, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1856222 · Cited by 24

Antler stem cell exosomes alleviate pulmonary fibrosis via inhibiting recruitment of monocyte macrophage, rather than polarization of M2 macrophages in mice

Zhang, G., Shi, L., Li, J., Wang, S., Ren, J., Wang, D., Hu, P., Wang, Y., & Li, C. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01659-9 · Cited by 24

Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials

Macisaac, S., Somboonviboon, D., Scallan, C. J., & Kolb, M. R. J. (2024) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2024.2340723 · Cited by 25

Phospholipids of inhaled liposomes determine the in vivo fate and therapeutic effects of salvianolic acid B on idiopathic pulmonary fibrosis

Peng, J., Wang, Q., Sun, R., Zhang, K., Chen, Y. C., & Gong, Z. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.026 · Cited by 23

Polymeric Micelles for Pulmonary Drug Delivery: A Comprehensive Review

Teama, M. T., Abdelmalak, N. S., Naguib, M. J., & Ahmed, S. (2025) · BioNanoScience · doi:10.1007/s12668-025-02105-z · Cited by 23

New trajectories in the treatment of interstitial lung disease

Morisset, J., & Lee, J. S. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000600 · Cited by 23

Regulatory Effect of PD1/PD-Ligand 1 (PD-L1) on Treg Cells in Patients with Idiopathic Pulmonary Fibrosis

Wang, B., Bai, W., Ma, H., & Li, F. (2020) · Medical Science Monitor · doi:10.12659/msm.927577 · Cited by 23

Arginine is a key player in fibroblasts during the course of IPF development

Wang, Y., Zhao, J., Zhang, H., & Wang, C. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.02.023 · Cited by 23

Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responses

Wang, P., Leung, J., Lam, A., Lee, S., Calabrese, D. R., Hays, S. R., Golden, J. A., Kukreja, J., Singer, J. P., Wolters, P. J., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.11.012 · Cited by 24

FGF19 is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits Lung Fibrosis in Mice

Justet, A., Ghanem, M., Boghanim, T., Hachem, M., Vasarmidi, E., Jaillet, M., Vadel, A., Joannes, A., Mordant, P., Bonniaud, P., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0246oc · Cited by 26

Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis

Sehgal, M., Jakhete, S. M., Manekar, A. G., & Sasikumar, S. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09773 · Cited by 23

Peimine ameliorates pulmonary fibrosis via the inhibition of M2-type macrophage polarization through the suppression of P38/Akt/STAT6 signals

Cai, Z., Tian, Y., Li, J.-Z., Zhao, P., Li, J., Mei, X., & Bai, Y. (2022) · Bioscience Reports · doi:10.1042/bsr20220986 · Cited by 23

Extracellular vesicles as advanced therapeutics for the resolution of organ fibrosis: Current progress and future perspectives

Lv, K., Wang, Y., Lou, P., Liu, S., Zhou, P., Yang, L., Lu, Y., Cheng, J., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1042983 · Cited by 24

TRIB3 Mediates Fibroblast Activation and Fibrosis though Interaction with ATF4 in IPF

Wang, L., Zhao, W., Xia, C., Li, Z., Zhao, W., Xu, K., Wang, N., Lian, H., Rosas, I. O., & Yu, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415705 · Cited by 24

Cuproptosis-related gene CDKN2A as a molecular target for IPF diagnosis and therapeutics

Xu, B., Yang, K., Han, X., & Hou, J. (2023) · Inflammation Research · doi:10.1007/s00011-023-01739-7 · Cited by 24

Polydatin alleviates bleomycin‐induced pulmonary fibrosis and alters the gut microbiota in a mouse model

Yang, J., Shi, X., Gao, R., Fan, L., Chen, R., Cao, Y., Xu, T., & Yang, J. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17937 · Cited by 24

Efficacy and safety of combination therapy with pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis

Huh, J.-Y., Lee, J. H., & Song, J. W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1301923 · Cited by 25

Nanomedicines for targeted pulmonary delivery: receptor-mediated strategy and alternatives

Wang, W., Zhong, Z., Huang, Z., Hiew, T. N., Huang, Y., Wu, C., & Pan, X. (2024) · Nanoscale · doi:10.1039/d3nr05487j · Cited by 26

Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications

Bonadio, J. D., Bashiri, G., Halligan, P., Kegel, M., Ahmed, F., & Wang, K. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115303 · Cited by 24

Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis

Sakayori, M., Terada, J., Abe, M., Hirasawa, Y., Suzuki, K., Yoshioka, K., Tsushima, K., & Tatsumi, K. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s208733 · Cited by 23

The protective effect of Hederagenin on pulmonary fibrosis by regulating the Ras/JNK/NFAT4 axis in rats

Ma, W., Huang, Q., Xiong, G., Deng, L., & He, Y. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1721263 · Cited by 23

Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success

Brunetti, G., Malovini, A. L., Maniscalco, M., Balestrino, A., Carone, M., Visca, D., Capelli, A., Vitacca, M., Bellazzi, R., Piaggi, G., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106473 · Cited by 23

Indole-3-acetic acid attenuates pulmonary fibrosis by modulating lung microbiota, inhibiting fibroblast activation, and alleviating alveolar epithelial cell senescence

Zhuo, J., Liu, D., Yu, Q., Hu, M., Huang, H., Chen, Y., Li, Y., Gao, Y., Chen, W., Meng, X., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123191 · Cited by 23

Aging Lung: Molecular Drivers and Impact on Respiratory Diseases—A Narrative Clinical Review

Górski, P., Białas, A. J., & Piotrowski, W. J. (2024) · Antioxidants · doi:10.3390/antiox13121480 · Cited by 25

Dopamine D1 receptor stimulates cathepsin K-dependent degradation and resorption of collagen I in lung fibroblasts

Espinosa, A. M. D., Link, P. A., Sicard, D., Jorba, I., Tschumperlin, D. J., & Haak, A. J. (2020) · Journal of Cell Science · doi:10.1242/jcs.248278 · Cited by 25

Chelerythrine Ameliorates Pulmonary Fibrosis via Activating the Nrf2/ARE Signaling Pathway

Peng, L., Li, W., Shi, Q., Gao, F., Huang, B., & Wang, C. (2021) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-021-00967-0 · Cited by 22

Roles of phosphatidyl inositol 3 kinase gamma (PI3Kγ) in respiratory diseases

Sala, V., Sala, A. D., Ghigo, A., & Hirsch, E. (2021) · Cell Stress · doi:10.15698/cst2021.04.246 · Cited by 23

Type 2 Alveolar Epithelial Cells Differentiated from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Mouse Pulmonary Fibrosis Through β-Catenin-Regulated Cell Apoptosis

Liu, J., Peng, D.-Y., You, J., Ou, Z., Qiu, H., Hao, C., Chen, H., Fu, Z., & Zou, L. (2021) · Stem Cells and Development · doi:10.1089/scd.2020.0208 · Cited by 23

Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis

Chen, Q., Xia, S., Sui, H. X., Shi, X., Huang, B., & Wang, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262737 · Cited by 22

Engineering of Stimulus-Responsive Pirfenidone Liposomes for Pulmonary Delivery During Treatment of Idiopathic Pulmonary Fibrosis

Han, M., Song, Y., Liu, S., Lu, X., Su, L., Liu, M., Zhu, X., Sun, K., Lu, Y., & Wang, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.882678 · Cited by 22

Aprepitant exerts anti-fibrotic effect via inhibition of TGF-β/Smad3 pathway in bleomycin-induced pulmonary fibrosis in rats

Mohamed, M. Z., Baky, M. F. A. E., Ali, M. E., & Hafez, H. M. (2022) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2022.103940 · Cited by 22

DDR1 activation in macrophage promotes IPF by regulating NLRP3 inflammasome and macrophage reaction

Wang, H., Wen, Y., Wang, L., Wang, J., Chen, H., Chen, J., Guan, J., Xie, S., Chen, Q. P., Wang, Y., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109294 · Cited by 23

Pronostic et exacerbations aiguës de la fibrose pulmonaire idiopathique

Uzunhan, Y. (2010) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(10)70127-0

Idiopathic Pulmonary Fibrosis: An Overview

May, J., & Jenkins, G. R. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm50844 · Cited by 1

New Aspects of Idiopathic Pulmonary Fibrosis

Molina‐Molina, M., Vicens, V., & Estany, S. (2010) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0b013e3181e4bb22 · Cited by 1

Re-dimensioning the treatment paradigm in idiopathic pulmonary fibrosis

Richeldi, L. (2018) · Monografías de Archivos de Bronconeumología

Idiopathic pulmonary fibrosis and progressive fibrotic interstitial lung disease

Evans, P., Rowlands, E., & Hope‐Gill, B. (2023) · Medicine · doi:10.1016/j.mpmed.2023.09.001 · Cited by 3